Offered by: Nemours Children's Health
Location: Jacksonville and Pensacola in Florida
A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection
What is the trial about?
The purpose of this research study is to compare the treatment experience of a weekly Somatrogon injection schedule and a daily Genotropin® (somatropin) injection schedule.
Who can participate?
Children with who have either isolated Growth Hormone Deficiency (GHD) or Growth Hormone insufficiency and are ages 3 to under 18.
What is involved?
Your child will be in this research study for about 24 weeks. Your child will need to visit the research site at least 6 times during the study and you will be called at least 3 times during the study.
There are 3 blood draws during this study.
Contact Nemours Clinical Trials
Trial Name: A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection